The role of DNA base excision repair in brain homeostasis and disease

DNA Repair

Volumn 32, Issue , 2015, Pages 172-179

  Akbari, Mansour ^a   Morevati, Marya ^a   Croteau, Deborah ^b   Bohr, Vilhelm A ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Base excision repair; Mitochondrial DNA; Neurodegeneration; Oxidative damage; PARP 1

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ATAXIA WITH OCULOMOTOR APRAXIA 1; ATM PROTEIN; CELL NUCLEUS DNA; COCKAYNE SYNDROME GROUP B PROTEIN; MITOCHONDRIAL DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PHOSPHATASE; PHOSPHODIESTERASE; POLYNUCLEOTIDE KINASE PHOSPHATASE; TYROSYL DNA PHOSPHODIESTERASE 1; UNCLASSIFIED DRUG; DNA HELICASE; DNA LIGASE; ERCC6 PROTEIN, HUMAN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, HUMAN; PHOSPHOTRANSFERASE; PNKP PROTEIN, HUMAN;

ALZHEIMER DISEASE; ARTICLE; BIOENERGY; BRAIN DISEASE; BRAIN ISCHEMIA; CELL COMPARTMENTALIZATION; CELL ENERGY; CEREBROVASCULAR ACCIDENT; CHEMICAL MODIFICATION; DNA DAMAGE; EXCISION REPAIR; HOMEOSTASIS; HUMAN; HUNTINGTON CHOREA; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BRAIN; CHEMISTRY; DEGENERATIVE DISEASE; DNA REPAIR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MITOCHONDRION; PATHOLOGY;

BRAIN; DNA DAMAGE; DNA HELICASES; DNA REPAIR; DNA REPAIR ENZYMES; DNA, MITOCHONDRIAL; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLY(ADP-RIBOSE) POLYMERASES;

EID: 84938213781     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2015.04.029     Document Type: Article

References (136)

1. Salminen L.E., Paul R.H. Oxidative stress and genetic markers of suboptimal antioxidant defense in the aging brain: a theoretical review. Rev. Neurosci. 2014, 25:805-819.
2. Lauritzen K.H., Moldestad O., Eide L., et al. Mitochondrial DNA toxicity in forebrain neurons causes apoptosis, neurodegeneration, and impaired behavior. Mol. Cell. Biol. 2010, 30:1357-1367.
3. Yang J.L., Tadokoro T., Keijzers G., et al. Neurons efficiently repair glutamate-induced oxidative DNA damage by a process involving CREB-mediated up-regulation of apurinic endonuclease 1. J. Biol. Chem. 2010, 285:28191-28199.
4. Suberbielle E., Sanchez P.E., Kravitz A.V., et al. Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-beta. Nat. Neurosci. 2013, 16:613-621.
5. Fan J., Wilson 3rd D.M. Protein-protein interactions and posttranslational modifications in mammalian base excision repair. Free Radical Biol. Med. 2005, 38:1121-1138.
6. Sykora P., Yang J.L., Ferrarelli L.K., et al. Modulation of DNA base excision repair during neuronal differentiation. Neurobiol. Aging 2013, 34:1717-1727.
7. Sjolund A.B., Senejani A.G., Sweasy J.B. MBD4 and TDG: multifaceted DNA glycosylases with ever expanding biological roles. Mutat. Res. 2013, 743-744:12-25.
8. Rada C., Williams G.T., Nilsen H., et al. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol.: CB 2002, 12:1748-1755.
9. Jobert L., Skjeldam H.K., Dalhus B., et al. The human base excision repair enzyme SMUG1 directly interacts with DKC1 and contributes to RNA quality control. Mol. Cell 2013, 49:339-345.
10. Krokan H.E., Saetrom P., Aas P.A., et al. Error-free versus mutagenic processing of genomic uracil-relevance to cancer. DNA Repair 2014, 19:38-47.
11. Nilsen H., Otterlei M., Haug T., et al. Nuclear and mitochondrial uracil-DNA glycosylases are generated by alternative splicing and transcription from different positions in the UNG gene. Nucleic Acids Res. 1997, 25:750-755.
12. Lakshmipathy U., Campbell C. The human DNA ligase III gene encodes nuclear and mitochondrial proteins. Mol. Cell. Biol. 1999, 19:3869-3876.
13. Li M., Zhong Z., Zhu J., et al. Identification and characterization of mitochondrial targeting sequence of human apurinic/apyrimidinic endonuclease 1. J. Biological Chem. 2010, 285:14871-14881.
14. Karahalil B., Hogue B.A., de Souza-Pinto N.C., Bohr V.A. Base excision repair capacity in mitochondria and nuclei: tissue-specific variations. FASEB J. 2002, 16:1895-1902.
15. Haug T., Skorpen F., Aas P.A., et al. Regulation of expression of nuclear and mitochondrial forms of human uracil-DNA glycosylase. Nucleic Acids Res. 1998, 26:1449-1457.
16. Hardeland U., Kunz C., Focke F., et al. Cell cycle regulation as a mechanism for functional separation of the apparently redundant uracil DNA glycosylases TDG and UNG2. Nucleic Acids Res. 2007, 35:3859-3867.
17. Narciso L., Fortini P., Pajalunga D., et al. Terminally differentiated muscle cells are defective in base excision DNA repair and hypersensitive to oxygen injury. Proc. Natl. Acad. Sci. U. S. A 2007, 104:17010-17015.
18. Hagen L., Kavli B., Sousa M.M., et al. Cell cycle-specific UNG2 phosphorylations regulate protein turnover, activity and association with RPA. EMBO J. 2008, 27:51-61.
19. Hanssen-Bauer A., Solvang-Garten K., Sundheim O., et al. XRCC1 coordinates disparate responses and multiprotein repair complexes depending on the nature and context of the DNA damage. Environ. Mol. Mutagen. 2011, 52:623-635.
20. Akbari M., Solvang-Garten K., Hanssen-Bauer A., et al. Direct interaction between XRCC1 and UNG2 facilitates rapid repair of uracil in DNA by XRCC1 complexes. DNA Repair 2010, 9:785-795.
21. Rolseth V., Runden-Pran E., Luna L., et al. Widespread distribution of DNA glycosylases removing oxidative DNA lesions in human and rodent brains. DNA Repair 2008, 7:1578-1588.
22. Imai K., Slupphaug G., Lee W.I., et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 2003, 4:1023-1028.
23. Barnes D.E., Tomkinson A.E., Lehmann A.R., et al. Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents. Cell 1992, 69:495-503.
24. Chow E., Thirlwell C., Macrae F., Lipton L. Colorectal cancer and inherited mutations in base-excision repair. The Lancet Oncol. 2004, 5:600-606.
25. Wilson 3rd D.M., Kim D., Berquist A.J. Variation in base excision repair capacity. Mutat. Res. 2011, 711:100-112.
26. Karahalil B., Bohr V.A., Wilson 3rd D.M. Impact of DNA polymorphisms in key DNA base excision repair proteins on cancer risk. Hum. Exp. Toxicol. 2012, 31:981-1005.
27. Sykora P., Wilson 3rd D.M., Bohr V.A. Base excision repair in the mammalian brain: implication for age related neurodegeneration. Mech. Ageing Dev. 2013, 134:440-448.
28. Wallace S.S. Base excision repair: a critical player in many games. DNA Repair 2014, 19:14-26.
29. Wallace S.S. DNA glycosylases search for and remove oxidized DNA bases. Environ. Mol. Mutagen. 2013, 54:691-704.
30. Das A., Wiederhold L., Leppard J.B., et al. NEIL2-initiated, APE-independent repair of oxidized bases in DNA: evidence for a repair complex in human cells. DNA Repair 2006, 5:1439-1448.
31. Wiederhold L., Leppard J.B., Kedar P., et al. AP endonuclease-independent DNA base excision repair in human cells. Mol. Cell 2004, 15:209-220.
32. Tahbaz N., Subedi S., Weinfeld M. Role of polynucleotide kinase/phosphatase in mitochondrial DNA repair. Nucleic Acids Res. 2012, 40:3484-3495.
33. Mandal S.M., Hegde M.L., Chatterjee A., et al. Role of human DNA glycosylase Nei-like 2 (NEIL2) and single strand break repair protein polynucleotide kinase 3'-phosphatase in maintenance of mitochondrial genome. J. Biol. Chem. 2012, 287:2819-2829.
34. Shen J., Gilmore E.C., Marshall C.A., et al. Mutations in PNKP cause microcephaly, seizures and defects in DNA repair. Nat. Genet. 2010, 42:245-249.
35. DiGiovanna J.J., Kraemer K.H. Shining a light on xeroderma pigmentosum. J. Invest. Dermatol. 2012, 132:785-796.
36. Ellenberger T., Tomkinson A.E. Eukaryotic DNA ligases: structural and functional insights. Annu. Rev. Biochem. 2008, 77:313-338.
37. Ahel I., Rass U., El-Khamisy S.F., et al. The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates. Nature 2006, 443:713-716.
38. Caglayan M., Batra V.K., Sassa A., et al. Role of polymerase beta in complementing aprataxin deficiency during abasic-site base excision repair. Nat. Struct. Mol. Biol. 2014, 21:497-499.
39. Date H., Onodera O., Tanaka H., et al. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat. Genet. 2001, 29:184-188.
40. Moreira M.C., Barbot C., Tachi N., et al. The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat. Genet. 2001, 29:189-193.
41. Clements P.M., Breslin C., Deeks E.D., et al. The ataxia-oculomotor apraxia 1 gene product has a role distinct from ATM and interacts with the DNA strand break repair proteins XRCC1 and XRCC4. DNA Repair 2004, 3:1493-1502.
42. El-Khamisy S.F., Katyal S., Patel P., et al. Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin. DNA Repair 2009, 8:760-766.
43. Sykora P., Croteau D.L., Bohr V.A., Wilson 3rd D.M. Aprataxin localizes to mitochondria and preserves mitochondrial function. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:7437-7442.
44. Tumbale P., Williams J.S., Schellenberg M.J., et al. Aprataxin resolves adenylated RNA-DNA junctions to maintain genome integrity. Nature 2014, 506:111-115.
45. Takashima H., Boerkoel C.F., John J., et al. Mutation of TDP1 encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat. Genet. 2002, 32:267-272.
46. Pommier Y., Huang S.Y., Gao R., et al. Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2). DNA Repair 2014, 19:114-129.
47. El-Khamisy S.F., Saifi G.M., Weinfeld M., et al. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature 2005, 434:108-113.
48. Das B.B., Dexheimer T.S., Maddali K., Pommier Y. Role of tyrosyl-DNA phosphodiesterase (TDP1) in mitochondria. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:19790-19795.
49. Katyal S., el-Khamisy S.F., Russell H.R., et al. TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo. EMBO J. 2007, 26:4720-4731.
50. Guo D., Dexheimer T.S., Pommier Y., Nash H.A. Neuroprotection and repair of 3'-blocking DNA ends by glaikit (gkt) encoding Drosophila tyrosyl-DNA phosphodiesterase 1 (TDP1). Proc. Natl. Acad. Sci. U. S. A. 2014, 111:15816-15820.
51. Fouquerel E., Sobol R.W. ARTD1 (PARP1) activation and NAD(+) in DNA repair and cell death. DNA Repair 2014, 23:27-32.
52. Okano S., Lan L., Caldecott K.W., et al. Spatial and temporal cellular responses to single-strand breaks in human cells. Mol. Cell. Biol. 2003, 23:3974-3981.
53. Guarente L. Linking DNA Damage, NAD(+)/SIRT1, and Aging. Cell Metab. 2014, 20:706-707.
54. Imai S., Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014, 24:464-471.
55. Liu D., Pitta M., Mattson M.P. Preventing NAD(+) depletion protects neurons against excitotoxicity: bioenergetic effects of mild mitochondrial uncoupling and caloric restriction. Annu. N. Y. Acad. Sci. 2008, 1147:275-282.
56. Liu D., Gharavi R., Pitta M., et al. Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons. Neuromol. Med. 2009, 11:28-42.
57. Oka S., Ohno M., Tsuchimoto D., et al. Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs. EMBO J. 2008, 27:421-432.
58. Sheng Z., Oka S., Tsuchimoto D., et al. 8-Oxoguanine causes neurodegeneration during MUTYH-mediated DNA base excision repair. J. Clin. Invest. 2012, 122:4344-4361.
59. Fang E.F., Scheibye-Knudsen M., Brace L.E., et al. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction. Cell 2014, 157:882-896.
60. Scheibye-Knudsen M., Mitchell S.J., Fang E.F., et al. A high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in Cockayne syndrome. Cell Metab. 2014, 20:840-855.
61. Kamenisch Y., Berneburg M. Mitochondrial CSA and CSB: protein interactions and protection from ageing associated DNA mutations. Mech. Ageing Dev. 2013, 134:270-274.
62. Aamann M.D., Muftuoglu M., Bohr V.A., Stevnsner T. Multiple interaction partners for Cockayne syndrome proteins: implications for genome and transcriptome maintenance. Mech. Ageing Dev. 2013, 134:212-224.
63. Kristensen U., Epanchintsev A., Rauschendorf M.A., et al. Regulatory interplay of Cockayne syndrome B ATPase and stress-response gene ATF3 following genotoxic stress. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E2261-2270.
64. Berquist B.R., Canugovi C., Sykora P., et al. Human Cockayne syndrome B protein reciprocally communicates with mitochondrial proteins and promotes transcriptional elongation. Nucleic Acids Res. 2012, 40:8392-8405.
65. Frontini M., Proietti-De-Santis L. Interaction between the Cockayne syndrome B and p53 proteins: implications for aging. Aging 2012, 4:89-97.
66. Marteijn J.A., Lans H., Vermeulen W., Hoeijmakers J.H. Understanding nucleotide excision repair and its roles in cancer and ageing. Nat. Rev. Mol. Cell Biol. 2014, 15:465-481.
67. Trapp C., Reite K., Klungland A., Epe B. Deficiency of the Cockayne syndrome B (CSB) gene aggravates the genomic instability caused by endogenous oxidative DNA base damage in mice. Oncogene 2007, 26:4044-4048.
68. Tuo J., Jaruga P., Rodriguez H., et al. Primary fibroblasts of Cockayne syndrome patients are defective in cellular repair of 8-hydroxyguanine and 8-hydroxyadenine resulting from oxidative stress. FASEB J. 2003, 17:668-674.
69. Aamann M.D., Hvitby C., Popuri V., et al. Cockayne Syndrome group B protein stimulates NEIL2 DNA glycosylase activity. Mech. Ageing Dev. 2014, 135:1-14.
70. Muftuoglu M., de Souza-Pinto N.C., Dogan A., et al. Cockayne syndrome group B protein stimulates repair of formamidopyrimidines by NEIL1 DNA glycosylase. J. Biol. Chem. 2009, 284:9270-9279.
71. Wong H.K., Muftuoglu M., Beck G., et al. Cockayne syndrome B protein stimulates apurinic endonuclease 1 activity and protects against agents that introduce base excision repair intermediates. Nucleic Acids Res. 2007, 35:4103-4113.
72. Banerjee D., Mandal S.M., Das A., et al. Preferential repair of oxidized base damage in the transcribed genes of mammalian cells. J. Biol. Chem. 2011, 286:6006-6016.
73. Thorslund T., von Kobbe C., Harrigan J.A., et al. Cooperation of the Cockayne syndrome group B protein and poly(ADP-ribose) polymerase 1 in the response to oxidative stress. Mol. Cell. Biol. 2005, 25:7625-7636.
74. Guo Z., Kozlov S., Lavin M.F., et al. ATM activation by oxidative stress. Science 2010, 330:517-521.
75. Eaton J.S., Lin Z.P., Sartorelli A.C., et al. Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis. J. Clin. Invest. 2007, 117:2723-2734.
76. Ambrose M., Goldstine J.V., Gatti R.A. Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells. Hum. Mol. Genet. 2007, 16:2154-2164.
77. Valentin-Vega Y.A., Maclean K.H., Tait-Mulder J., et al. Mitochondrial dysfunction in ataxia-telangiectasia. Blood 2012, 119:1490-1500.
78. Sharma N.K., Lebedeva M., Thomas T., et al. Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia. DNA Repair 2014, 13:22-31.
79. Akbari M., Keijzers G., Maynard S., et al. Overexpression of DNA ligase III in mitochondria protects cells against oxidative stress and improves mitochondrial DNA base excision repair. DNA Repair 2014, 16:44-53.
80. Guerreiro R.J., Gustafson D.R., Hardy J. The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiol. Aging 2012, 33:437-456.
81. Lu T., Aron L., Zullo J., et al. REST and stress resistance in ageing and Alzheimer's disease. Nature 2014, 507:448-454.
82. Wang X., Wang W., Li L., et al. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochim. Biophys. Acta 2014, 1842:1240-1247.
83. Ramamoorthy M., Sykora P., Scheibye-Knudsen M., et al. Sporadic Alzheimer disease fibroblasts display an oxidative stress phenotype. Free Radical Biol. Med. 2012, 53:1371-1380.
84. Lovell M.A., Soman S., Bradley M.A. Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain. Mech. Ageing Dev. 2011, 132:443-448.
85. Gabbita S.P., Lovell M.A., Markesbery W.R. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 1998, 71:2034-2040.
86. Weissman L., Jo D.G., Sorensen M.M., et al. Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment. Nucleic Acids Res. 2007, 35:5545-5555.
87. Canugovi C., Shamanna R.A., Croteau D.L., Bohr V.A. Base excision DNA repair levels in mitochondrial lysates of Alzheimer's disease. Neurobiol. Aging 2014, 35:1293-1300.
88. Lovell M.A., Xie C., Markesbery W.R. Decreased base excision repair and increased helicase activity in Alzheimer's disease brain. Brain Res. 2000, 855:116-123.
89. Coskun P., Wyrembak J., Schriner S.E., et al. A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim. Biophys. Acta 2012, 1820:553-564.
90. Santos R.X., Correia S.C., Zhu X., et al. Nuclear and mitochondrial DNA oxidation in Alzheimer's disease. Free Radical Res. 2012, 46:565-576.
91. Wang J., Xiong S., Xie C., et al. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J. Neurochem. 2005, 93:953-962.
92. Cabelof D.C., Patel H.V., Chen Q., et al. Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome. Blood 2009, 114:2753-2763.
93. Busciglio J., Yankner B.A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 1995, 378:776-779.
94. Sykora P., Misiak M., Wang Y., et al. DNA polymerase beta deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes. Nucleic Acids Res. 2014.
95. Guzman J.N., Sanchez-Padilla J., Wokosin D., et al. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 2010, 468:696-700.
96. Schapira A.H., Cooper J.M., Dexter D., et al. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989, 1:1269.
97. Bender A., Krishnan K.J., Morris C.M., et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet. 2006, 38:515-517.
98. Simon D.K., Lin M.T., Zheng L., et al. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease. Neurobiol. Aging 2004, 25:71-81.
99. Sanders L.H., McCoy J., Hu X., et al. Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease. Neurobiol. Dis. 2014, 70:214-223.
100. Lin M.T., Cantuti-Castelvetri I., Zheng K., et al. Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease. Ann. Neurol. 2012, 71:850-854.
101. Duyao M.P., Auerbach A.B., Ryan A., et al. Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 1995, 269:407-410.
102. McMurray C.T. Mechanisms of trinucleotide repeat instability during human development. Nat. Rev. Genet. 2010, 11:786-799.
103. Kovtun I.V., Liu Y., Bjoras M., et al. OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 2007, 447:447-452.
104. Damiano M., Galvan L., Deglon N., Brouillet E. Mitochondria in Huntington's disease. Biochim. Biophys. Acta 2010, 1802:52-61.
105. Yano H., Baranov S.V., Baranova O.V., et al. Inhibition of mitochondrial protein import by mutant huntingtin. Nat. Neurosci. 2014, 17:822-831.
106. Mochel F., Haller R.G. Energy deficit in Huntington disease: why it matters?. J. Clin. Invest. 2011, 121:493-499.
107. Siddiqui A., Rivera-Sanchez S., Castro Mdel R., et al. Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease. Free Radical Biol. Med. 2012, 53:1478-1488.
108. Stack E.C., Matson W.R., Ferrante R.J. Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants. Annu. N. Y. Acad. Sci. 2008, 1147:79-92.
109. Costa V., Scorrano L. Shaping the role of mitochondria in the pathogenesis of Huntington's disease. EMBO J. 2012, 31:1853-1864.
110. Ayala-Pena S. Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis. Free Radical Biol. Med. 2013, 62:102-110.
111. Xun Z., Rivera-Sanchez S., Ayala-Pena S., et al. Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington's disease. Cell Rep. 2012, 2:1137-1142.
112. Ebrahimkhani M.R., Daneshmand A., Mazumder A., et al. Aag-initiated base excision repair promotes ischemia reperfusion injury in liver, brain, and kidney. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:E4878-4886.
113. Chen D., Minami M., Henshall D.C., et al. Upregulation of mitochondrial base-excision repair capability within rat brain after brief ischemia. J. Cereb. Blood Flow and Metab. 2003, 23:88-98.
114. Lan J., Li W., Zhang F., et al. Inducible repair of oxidative DNA lesions in the rat brain after transient focal ischemia and reperfusion. J. Cereb. Blood Flow and Metab. 2003, 23:1324-1339.
115. Tsuruya K., Furuichi M., Tominaga Y., et al. Accumulation of 8-oxoguanine in the cellular DNA and the alteration of the OGG1 expression during ischemia-reperfusion injury in the rat kidney. DNA Repair 2003, 2:211-229.
116. Endres M., Biniszkiewicz D., Sobol R.W., et al. Increased postischemic brain injury in mice deficient in uracil-DNA glycosylase. J. Clin. Invest. 2004, 113:1711-1721.
117. Liu D., Croteau D.L., Souza-Pinto N., et al. Evidence that OGG1 glycosylase protects neurons against oxidative DNA damage and cell death under ischemic conditions. J. Cereb. Blood Flow and Metab. 2011, 31:680-692.
118. Sejersted Y., Hildrestrand G.A., Kunke D., et al. Endonuclease VIII-like 3 (Neil3) DNA glycosylase promotes neurogenesis induced by hypoxia-ischemia. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:18802-18807.
119. Canugovi C., Yoon J.S., Feldman N.H., et al. Endonuclease VIII-like 1 (NEIL1) promotes short-term spatial memory retention and protects from ischemic stroke-induced brain dysfunction and death in mice. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:14948-14953.
120. Marchesi V.T. Alzheimer's disease and CADASIL are heritable, adult-onset dementias that both involve damaged small blood vessels. Cell. Mol. Life Sci.: CMLS 2014, 71:949-955.
121. Querfurth H.W., LaFerla F.M. Alzheimer's disease. N. Engl. J. Med. 2010, 362:329-344.
122. Canugovi C., Misiak M., Scheibye-Knudsen M., et al. Loss of NEIL1 causes defects in olfactory function in mice. Neurobiol. Aging 2014.
123. Devanand S., et al. Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community. Neurology,. 2014.
124. Israel M.A., Yuan S.H., Bardy C., et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 2012, 482:216-220.
125. Lu T., Pan Y., Kao S.Y., et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004, 429:883-891.
126. Horton J.K., Joyce-Gray D.F., Pachkowski B.F., et al. Hypersensitivity of DNA polymerase beta null mouse fibroblasts reflects accumulation of cytotoxic repair intermediates from site-specific alkyl DNA lesions. DNA Repair 2003, 2:27-48.
127. Harrison J.F., Hollensworth S.B., Spitz D.R., et al. Oxidative stress-induced apoptosis in neurons correlates with mitochondrial DNA base excision repair pathway imbalance. Nucleic Acids Res. 2005, 33:4660-4671.
128. Viswanathan A., You H.J., Doetsch P.W. Phenotypic change caused by transcriptional bypass of uracil in nondividing cells. Science 1999, 284:159-162.
129. Galashevskaya A., Sarno A., Vagbo C.B., et al. A robust, sensitive assay for genomic uracil determination by LC/MS/MS reveals lower levels than previously reported. DNA Repair 2013, 12:699-706.
130. Scheibye-Knudsen M., Ramamoorthy M., Sykora P., et al. Cockayne syndrome group B protein prevents the accumulation of damaged mitochondria by promoting mitochondrial autophagy. J. Exp. Med. 2012, 209:855-869.
131. Cummings J.L., Morstorf T., Zhong K. Alzheimer's disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res. Ther. 2014, 6:37.
132. Frost B., Gotz J., Feany M.B. Connecting the dots between tau dysfunction and neurodegeneration. Trends Cell Biol. 2015, 25:46-53.
133. Fu D., Calvo J.A., Samson L.D. Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat. Rev. Cancer 2012, 12:104-120.
134. Parsons J.L., Tait P.S., Finch D., et al. CHIP-mediated degradation and DNA damage-dependent stabilization regulate base excision repair proteins. Mol. Cell 2008, 29:477-487.
135. Parsons J.L., Dianova I.I., Khoronenkova S.V., et al. USP47 is a deubiquitylating enzyme that regulates base excision repair by controlling steady-state levels of DNA polymerase beta. Mol. Cell 2011, 41:609-615.
136. Hegre S.A., Saetrom P., Aas P.A., et al. Multiple microRNAs may regulate the DNA repair enzyme uracil-DNA glycosylase. DNA Repair 2013, 12:80-86.